Elekta AB (publ) (EKTA-B.ST)
Builds radiation therapy machines that treat cancer and brain tumors
48.88+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+4.4%
The outlook
Elekta trades near the lower quarter of its 52-week range and below both its 50- and 200-day moving averages, signaling a downtrend. Analysts hold a mixed stance with an average "Hold" rating, though their consensus price target sits roughly 23% above the current level. The overall data lean is bearish, reflecting near-term weakness despite longer-term analyst targets.
What’s behind the score
Analyst consensusHold — 3.1 avg of 14 analysts
Price trendBelow its 50- & 200-day averages
52-week range32% of the way from its 52-week low to high
Price targetAvg target +23% vs current price
Analyst price target
~12-month · 14 analysts60.32average target+23.4% vs now
Now 48.88
Low 41.00High 100.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$18.68B
52-wk high
66.70
52-wk low
40.64
50-day avg
51.79
200-day avg
54.04
Trailing P/E
—